Skip to main content
logo
Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.640
+0.147 (9.85%)
At close: Jul 31, 2026, 4:00 PM EDT
1.700
+0.060 (3.66%)
Pre-market: Aug 3, 2026, 5:56 AM EDT

Calidi Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
21384158581,3973,128
Market Cap Growth
-92.06%-66.78%-51.63%-38.56%-55.34%-
Enterprise Value
-2.38134.87412.99863.511,4113,357
Last Close Price
1.6418.72220.802899.2019526.4018835.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----31039.606966.38
PB Ratio
0.2536.69270.61-104.22-27.69-212.97
P/TBV Ratio
0.131.346.00---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----31352.207476.27

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.281.32-0.65-0.040
Net Debt / Equity Ratio
-0.89-0.81-1.67-0.64-0.090.07
Net Debt / EBITDA Ratio
0.250.160.13-0.19-0.190.10
Net Debt / FCF Ratio
0.240.140.13-0.19-0.330.13
Asset Turnover
-0000.000.00
Quick Ratio
1.731.421.010.190.012.59
Current Ratio
1.921.591.080.420.023.61
Return on Equity (ROE)
-439.59%-700.65%708.76%119.07%-29.15%-5.08%
Return on Assets (ROA)
-210.12%-175.83%-180.07%-459.86%-19.75%-4.53%
Return on Invested Capital (ROIC)
-3018.88%-29786.98%---26.62%-4.90%
Return on Capital Employed (ROCE)
-362.74%-421.32%-973.66%142.80%-24.22%-4.53%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-445.69%-544.98%----
Total Shareholder Return
-445.69%-544.98%----
SEC Filings: 10-K · 10-Q